Shire Adderall XR Sales Suspended In Canada; FDA Stands By "Black Box"
This article was originally published in The Pink Sheet Daily
Executive Summary
Company plans a "Dear Doctor" letter informing U.S. physicians of Health Canada's decision. FDA says it "has not decided to take any further regulatory action at this time"; sudden death warnings were added to Adderall XR's labeling in August.
You may also be interested in...
J&J's Evra Canadian Label Includes Obesity, Sauna Warnings
Revised labeling on risk of venous thromboembolism associated with the birth control patch in Canada appears stronger than FDA's revision on Ortho Evra.
J&J's Evra Canadian Label Includes Obesity, Sauna Warnings
Revised labeling on risk of venous thromboembolism associated with the birth control patch in Canada appears stronger than FDA's revision on Ortho Evra.
ADHD Individual Drug Risk Studies To Be Considered By Drug Safety Committee
FDA to present analysis of sudden death and serious cardiovascular event rates with amphetamine and methylphenidate products at Feb. 9 meeting of Drug Safety & Risk Management Advisory Committee.